- What does Asta do?
- The company develops, manufactures and sells MALDI-TOF mass spectrometry instruments and related consumables, founded in 2006 and listed as a technology-based firm. Its medical products, including the MicroIDsys LT, Elite and Cyclone models for microbial identification, serve hospitals, testing centers and clinics, supported by a large bacteria database and cloud-based services. It also sells LDI-TOF instruments for industrial quality control in the display, secondary battery and semiconductor industries, and is expanding into overseas markets such as the Middle East, North Africa, Europe and Taiwan, with technology licensing as a new revenue stream.
- What is the market cap of Asta?
- The market capitalisation of Asta was ₩99B at the close on Oct 27, 2026.
- Who are the largest shareholders of Asta?
- According to the latest official filings, the largest reported holders are Jo Eung-jun (31.97%, as of Oct 23, 2026); Kim Yang-seon (15.43%, as of May 15, 2025); SD Biosensor (7.33%, as of Oct 20, 2026).
- When is the next earnings report from Asta?
- Korean companies rarely announce results dates in advance. Based on when Asta filed the same report in past years, its next 3q results is expected around Nov 14, 2026.